Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Amplify Seymour Cannabis ETF CNBS

The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.


ARCA:CNBS - Post by User

Amplify Seymour Cannabis ETF
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by Bullknit101on May 17, 2022 4:09pm
64 Views
Post# 34690287

Tim Seymour - Pay Attention To This One

Tim Seymour - Pay Attention To This One https://thedalesreport.com/interviews/inmed-pharmaceuticals-commercializing-the-development-of-rare-cannabinoids-for-the-wellness-market/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities